全文获取类型
| 收费全文 | 928639篇 |
| 免费 | 75097篇 |
| 国内免费 | 2190篇 |
专业分类
| 耳鼻咽喉 | 13849篇 |
| 儿科学 | 26863篇 |
| 妇产科学 | 26340篇 |
| 基础医学 | 132934篇 |
| 口腔科学 | 28559篇 |
| 临床医学 | 79779篇 |
| 内科学 | 180407篇 |
| 皮肤病学 | 19108篇 |
| 神经病学 | 75945篇 |
| 特种医学 | 36789篇 |
| 外国民族医学 | 173篇 |
| 外科学 | 144791篇 |
| 综合类 | 25404篇 |
| 现状与发展 | 2篇 |
| 一般理论 | 285篇 |
| 预防医学 | 72823篇 |
| 眼科学 | 22258篇 |
| 药学 | 69249篇 |
| 5篇 | |
| 中国医学 | 2074篇 |
| 肿瘤学 | 48289篇 |
出版年
| 2018年 | 10234篇 |
| 2016年 | 8202篇 |
| 2015年 | 9463篇 |
| 2014年 | 13351篇 |
| 2013年 | 19967篇 |
| 2012年 | 27781篇 |
| 2011年 | 29527篇 |
| 2010年 | 16717篇 |
| 2009年 | 15079篇 |
| 2008年 | 26843篇 |
| 2007年 | 28843篇 |
| 2006年 | 28358篇 |
| 2005年 | 27901篇 |
| 2004年 | 27191篇 |
| 2003年 | 26029篇 |
| 2002年 | 24789篇 |
| 2001年 | 37676篇 |
| 2000年 | 38675篇 |
| 1999年 | 32284篇 |
| 1998年 | 9621篇 |
| 1997年 | 8816篇 |
| 1996年 | 8724篇 |
| 1995年 | 8209篇 |
| 1994年 | 7898篇 |
| 1992年 | 26961篇 |
| 1991年 | 26384篇 |
| 1990年 | 25860篇 |
| 1989年 | 24882篇 |
| 1988年 | 23429篇 |
| 1987年 | 23056篇 |
| 1986年 | 21880篇 |
| 1985年 | 21237篇 |
| 1984年 | 16518篇 |
| 1983年 | 14110篇 |
| 1982年 | 8917篇 |
| 1981年 | 8258篇 |
| 1980年 | 7735篇 |
| 1979年 | 16809篇 |
| 1978年 | 12179篇 |
| 1977年 | 10217篇 |
| 1976年 | 9367篇 |
| 1975年 | 10201篇 |
| 1974年 | 12682篇 |
| 1973年 | 12192篇 |
| 1972年 | 11576篇 |
| 1971年 | 10736篇 |
| 1970年 | 10248篇 |
| 1969年 | 9950篇 |
| 1968年 | 8940篇 |
| 1967年 | 8291篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
51.
52.
53.
54.
Paul J. Devlin Brian W. McCrindle James K. Kirklin Eugene H. Blackstone William M. DeCampli Christopher A. Caldarone Ali Dodge-Khatami Pirooz Eghtesady James M. Meza Peter J. Gruber Kristine J. Guleserian Bahaaladin Alsoufi Linda M. Lambert James E. O&#x;Brien Erle H. Austin Jeffrey P. Jacobs Tara Karamlou 《The Journal of thoracic and cardiovascular surgery》2019,157(2):684-695.e8
Objective
Arch obstruction after the Norwood procedure is common and contributes to mortality. We determined the prevalence, associated factors, and practice variability of arch reintervention and assessed whether arch reintervention is associated with mortality.Methods
From 2005 to 2017, 593 neonates in the Congenital Heart Surgeons' Society Critical Left Heart Obstruction cohort underwent a Norwood procedure. Median follow-up was 3.7 years. Multivariable parametric models, including a modulated renewal analysis, were performed.Results
Of the 593 neonates, 146 (25%) underwent 218 reinterventions for arch obstruction after the Norwood procedure: catheter-based (n = 168) or surgical (n = 50) at a median age of 4.3 months (quartile 1-quartile 3, 2.6-5.7). Interdigitation of the distal aortic anastomosis was protective against arch reintervention. Development of ≥ moderate tricuspid valve regurgitation and right ventricular dysfunction at any point was associated with arch reintervention. Nonsignificant variables for arch reintervention included shunt type and preoperative aortic measurements. Surgical arch reintervention was protective against arch reintervention, but transcatheter reintervention was associated with increased reintervention. Arch reintervention was not associated with increased mortality. There was wide institutional variation in incidence of arch reintervention (range, 0-40 reinterventions per 100 years patient follow-up) and in preintervention gradient (range, 0-64 mm Hg).Conclusions
Interdigitation of the distal aortic anastomosis during the Norwood procedure decreased the risk of arch reintervention. Surgical arch reintervention is more definitive than transcatheter. Arch reintervention after the Norwood procedure is not associated with increased mortality. Serial surveillance for arch obstruction, integrated with changes in right ventricular function and tricuspid valve regurgitation, is recommended after the Norwood procedure to improve outcomes. 相似文献55.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献56.
Focal hyperhidrosis secondary to eccrine naevus successfully treated with botulinum toxin type A 
下载免费PDF全文
下载免费PDF全文 Eccrine naevus (EN) is a rare skin hamartoma included in the organoid group of epidermal naevi, histologically defined as focal hyperplasia and/or hypertrophy of eccrine glands. Clinically, EN usually presents as hyperhidrotic patches with no visible skin changes, frequently located on the forearms. The decision to treat EN or not usually depends on the grade of hyperhidrosis, but there is no therapeutic consensus because of the rarity of this condition. We present a case diagnosed as EN in an adult patient with severe localized hyperhidrosis, which was successfully treated with botulinum toxin. 相似文献
57.
58.
59.
60.